Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma.

Journal: eLife

Published: 2020-06-09

DOI: 10.7554/elife.53367

Affiliations: 12

Authors: 14

Go to article
Institutions Share
The Kinghorn Cancer Centre (TKCC), Australia 0.51
Crown Princess Mary Cancer Centre Westmead, WSLHD, Australia 0.11
Blacktown and Mount Druitt Hospital (BMDH), Australia 0.11
St Vincent's Clinical School (STVCS), UNSW Sydney, Australia 0.08
ANZAC Research Institute, Australia 0.04
Faculty of Medicine and Health, USYD, Australia 0.04
St Vincent's Hospital Sydney, Australia 0.02
UCD School of Medicine and Medical Science (UCD Medicine), Ireland 0.02
Hudson Institute of Medical Research, Australia 0.02
Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia 0.02
Research Institute in Oncology and Hematology (RIOH), Canada 0.02
Rady Faculty of Health Sciences, University of Manitoba, Canada 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER